News
SPRC
3.320
-7.52%
-0.270
Weekly Report: what happened at SPRC last week (0330-0403)?
Weekly Report · 2d ago
Weekly Report: what happened at SPRC last week (0323-0327)?
Weekly Report · 03/30 10:09
Scisparc Director Alon Dayan Files Initial Beneficial Ownership Statement
Reuters · 03/23 20:01
Weekly Report: what happened at SPRC last week (0316-0320)?
Weekly Report · 03/23 10:06
Psychedelic: AtaiBeckley reports publication of BPL-003 study results
TipRanks · 03/19 15:45
Scisparc Ltd. files initial beneficial ownership statement for Director Shay Amnon Ben Shay
Reuters · 03/18 20:02
SciSparc Ltd. CEO and CFO Oz Adler Files Initial Beneficial Ownership Statement
Reuters · 03/18 20:02
Scisparc Ltd. Director Moshe Revach Files Initial Beneficial Ownership Statement
Reuters · 03/18 20:02
SciSparc Ltd. Director Itschak Shrem Files Initial Beneficial Ownership Statement
Reuters · 03/18 20:02
SciSparc Ltd. files initial beneficial ownership statement for CTO Adi Zuloff-Shani
Reuters · 03/18 20:02
Scisparc Ltd. files Form 3 initial beneficial ownership statement for Director Lior Vider
Reuters · 03/18 20:02
SciSparc’s NeuroThera-Backed Collaboration Spurs New Depression Therapy Patent Filing
TipRanks · 03/16 20:29
SciSparc discloses patent application for depression yherapy
TipRanks · 03/16 12:25
NeuroThera Labs files Hong Kong patent application for MEAI-PEA depression therapy
Reuters · 03/16 12:20
SCISPARC: NEUROTHERA LABS- CLEARMIND MEDICINE COLLABORATION LEADS TO PATENT APPLICATION FOR DEPRESSION THERAPY
Reuters · 03/16 12:20
Weekly Report: what happened at SPRC last week (0309-0313)?
Weekly Report · 03/16 10:06
SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy
Barchart · 03/16 07:20
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 03/13 21:05
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 03/13 12:05
SciSparc Subsidiary NeuroThera Labs Supplies PEA for Clearmind Depression Patent Filing in Hong Kong
Reuters · 03/13 11:45
More
Webull provides a variety of real-time SPRC stock news. You can receive the latest news about Scisparc through multiple platforms. This information may help you make smarter investment decisions.
About SPRC
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.